Revenue: As of FY2025 Q3, the actual value is USD 49.85 M, beating the estimate of USD 49.73 M.EPS: As of FY2025 Q3, the actual value is USD 0.21.EBIT: As of FY2025 Q3, the actual value is USD 28.08 M.<h3>Segment Revenue</h3><ul><li>Rental Revenue: For the three months ended September 30, 2025, rental revenue was $49,421,000, an increase from $46,118,000 in the same period in 2024. For the nine months ended September 30, 2025, rental revenue was $146,221,000, up from $140,311,000 in 2024.</li><li>Real Estate Related Notes Receivable Interest Income: For the three months ended September 30, 2025, interest income was $427,000, with a total of $615,000 for the nine months ended September 30, 2025.</li></ul><h3>Operational Metrics</h3><ul><li>Net Income: For the three months ended September 30, 2025, net income attributable to common stockholders was $11,609,000, compared to $11,935,000 in 2024. For the nine months ended September 30, 2025, net income was $28,105,000, down from $31,543,000 in 2024.</li><li>Depreciation and Amortization: For the three months ended September 30, 2025, depreciation and amortization expenses were $19,396,000, compared to $17,865,000 in 2024. For the nine months ended September 30, 2025, these expenses were $55,340,000, compared to $57,009,000 in 2024.</li><li>Operating Expenses: Total operating expenses for the three months ended September 30, 2025, were $30,004,000, compared to $29,312,000 in 2024. For the nine months ended September 30, 2025, operating expenses were $95,884,000, compared to $96,778,000 in 2024.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Provided by Operating Activities: For the nine months ended September 30, 2025, net cash provided by operating activities was $86,101,000, compared to $97,267,000 in 2024.</li><li>Net Cash Used in Investing Activities: For the nine months ended September 30, 2025, net cash used in investing activities was $168,080,000, compared to $149,024,000 in 2024.</li><li>Net Cash Provided by (Used in) Financing Activities: For the nine months ended September 30, 2025, net cash provided by financing activities was $69,844,000, compared to net cash used of $121,822,000 in 2024.</li></ul><h3>Unique Metrics</h3><ul><li>Impairment and Disposition Losses: For the nine months ended September 30, 2025, impairment losses on real estate were $6,792,000, compared to $1,210,000 in 2024.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company continues to focus on investing in high-quality net lease healthcare facilities to generate predictable, durable, and growing income streams. The company plans to meet its long-term liquidity requirements through cash flows from operations, borrowings on its credit facility, and potential equity offerings.</li><li>Non-Core Business: The company has a commitment to fund a development to expand the Dover Healthcare Facility for up to $9,837,000.</li></ul>

Sila Realty Trust | 10-Q: FY2025 Q3 Revenue Beats Estimate at USD 49.85 M